223 related articles for article (PubMed ID: 18586294)
1. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
2. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
3. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
4. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
Kim J; Tipper C; Sodroski J
J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
[TBL] [Abstract][Full Text] [Related]
5. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
6. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
7. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
Li X; Song B; Xiang SH; Sodroski J
Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365
[TBL] [Abstract][Full Text] [Related]
8. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
9. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
[TBL] [Abstract][Full Text] [Related]
10. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
[TBL] [Abstract][Full Text] [Related]
12. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
13. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
Passerini LD; Keckesova Z; Towers GJ
J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
[TBL] [Abstract][Full Text] [Related]
14. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.
Li X; Sodroski J
J Virol; 2008 Dec; 82(23):11495-502. PubMed ID: 18799578
[TBL] [Abstract][Full Text] [Related]
15. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
16. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
[TBL] [Abstract][Full Text] [Related]
17. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
[TBL] [Abstract][Full Text] [Related]
18. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
Nakayama EE; Miyoshi H; Nagai Y; Shioda T
J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780
[TBL] [Abstract][Full Text] [Related]
19. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
Perez-Caballero D; Hatziioannou T; Yang A; Cowan S; Bieniasz PD
J Virol; 2005 Jul; 79(14):8969-78. PubMed ID: 15994791
[TBL] [Abstract][Full Text] [Related]
20. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.
Sebastian S; Grütter C; Strambio de Castillia C; Pertel T; Olivari S; Grütter MG; Luban J
J Virol; 2009 Apr; 83(7):3365-73. PubMed ID: 19153241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]